Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

I.V. dressing is basically transparent dressing used to protect I.V. sites or catheters to the insertion point and can also be used as secondary dressings. I.V. dressing allow the excess moisture while maintaining a moist wound healing environment which is necessary for wound healing and help to block the germs and keep catheter site dry and clean.

IV Dressing that consist of micro porous non-woven fabric (Polyethylene film), medical hypo-allergenic adhesive and absorbent pads.

Rising incidences of infections such as central line associated bloodstream infection (CLABSI), catheter-related bloodstream infection (CRBSI), and other infections are expected to boost growth of the I.V. dressing market over the forecast period. For instance, according to the data published in National Healthcare Safety Network’s Bloodstream Infection Surveillance in March 2018, around 30,000 CLABSI cases are reported every year in the U.S. CLABSI infection can prolong the hospital stay of the patients, which can increase the cost burden on patients and may also lead to mortality.

Furthermore, according to the International Society for Infectious Diseases: March 2018, around 250,000 cases of blood stream infections are reported every year in the U.S. Among these cases, around 80,000 are catheter-related bloodstream infections (CRBSI), which occur in intensive care units.

The global I.V. dressing market is estimated to be valued at US$ 724.2 million in 2021 and is expected to exhibit a CAGR of 5.7% over the forecast period (2021-2028).

Figure 1. Global I.V. Dressing Market Share (%) in Terms of Value, By Region, 2021

I.V. Dressing  | Coherent Market Insights

Increasing prevalence of chronic kidney diseases and significant number of dialysis procedures  is expected to drive the market growth over the forecast period.

Dialysis procedures require central venous catheter (CVC), hence, increasing prevalence of chronic kidney diseases and significant number of dialysis procedures in the region is expected to drive the growth of I.V. dressing market near the future

According to Brazilian Journal of Nephrology, in 2016, there were 834 registered dialysis centers, among which 747 dialysis centers were active for chronic dialysis programs. According to the Brazilian Journal of Nephrology, in 2017, an estimated 126,583 Brazilian patients were receiving dialysis treatment.

request-sample

I.V. Dressing Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 724.2 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 5.7% 2028 Value Projection: US$ 1,068.8 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Transparent, Translucent
  • By End User: Hospital, Clinics, Others
Companies covered:

Becton, Dickinson and Company, Lohmann & Rauscher, Komal Health Care Pvt. Ltd., Paul Hartmann AG, DeRoyal Industries Inc., Tytex, Shandong Dermcosy Medical Co., Ltd., Smith & Nephew plc, Dynarex Corporation, Talent Healthcare, 3M, and Datt Mediproducts Pvt. Limited

Growth Drivers:
  • Rising Incidence of Blood Infections And Number of Surgeries
  • Increasing Product Approvals And Launches
Restraints & Challenges:
  • Complications Associated with I.V. Dressing 

Figure 2. Global I.V. Dressing Market Share (%), by Product Type, 2021

I.V. Dressing  | Coherent Market Insights

Moreover, I.V. dressing market is expected to witness significant growth over the forecast period, owing to increasing number of surgeries that mostly requires I.V. dressing. For instance, according to National Health Statistics Report of 2017, an estimated 48.3 million surgical and non-surgical procedures were performed in the U.S., also in 2017. An estimated 25.7 million (53%) ambulatory surgery procedures were performed in hospitals and 22.5 million (47%) were performed in ambulatory surgical centers in the U.S.

Global I.V. Dressing Market– Impact of Coronavirus (COVID-19) Pandemic- COVID-19 Considerations for clinical management in the Catheterization Laboratory

The worldwide pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has placed enormous strain on the health care systems of the nations where it has spread widely, with specific implications on practice in the catheterization laboratory. These implications include how modifications in standard practice for cardiac patients are needed for those who are suspected to have COVID-19, and those with COVID-19.

At this time, to preserve hospital bed capacity, it would seem reasonable to avoid elective procedures on patients with significant comorbidities or in whom the expected length of stay is >1 to 2 days (or anticipated to require the intensive care unit). Examples of procedures to defer include:

  • Percutaneous coronary intervention for stable ischemic heart disease
  • Endovascular intervention for iliofemoral disease in patients with claudication and
  • Patent foramen ovale closure

Case decisions should be individualized, taking into account the risk for COVID-19 exposure versus the risk for delay in diagnosis or therapy

In a patient with known COVID-19 and ST-segment elevation myocardial infarction (STEMI), the balance of exposure of staff to the patient and patient benefit in terms of faster diagnosis and management will need to be weighed carefully

Fibrinolysis can be considered an option for a relatively stable patient with STEMI with active COVID-19. In patients with active COVID-19 in whom primary percutaneous coronary intervention is to be performed, appropriate personal protective equipment should be worn, including gown, gloves, goggles (or shields), and an N95 mask, especially given the limited ability to take a history from such patients as well as the potential for clinical deterioration in those with STEMI

Global I.V. Dressing Market Restraint

Complications associated with I.V. dressing are expected to hinder growth of the global I.V. dressing market. These complications include nausea, swelling, discomfort, and others. The most frequently reported peripheral intravenous catheter (PIVC) related complications include phlebitis, infiltration, obstruction, extravasation, accidental removal, and tube clogging.

Moreover, bacterial contamination of the I.V. dressing is also expected to limit growth of the market. Phlebitis is one of the most common complications of peripheral IV therapy, which puts the patient at an increased risk of erythema, pain, swelling, localized infection, and catheter-related bloodstream infections. Some of these complications include nasopharyngeal discomfort, pharyngeal or esophageal perforation, intraperitoneal bleeding, peristomal leaks, and gastrocolic fistula formation.

Key Players

Major players operating in the global I.V. dressing market include Becton, Dickinson and Company, Lohmann & Rauscher, Komal Health Care Pvt. Ltd., Paul Hartmann AG, DeRoyal Industries Inc., Tytex, Shandong Dermcosy Medical Co., Ltd., Smith & Nephew plc, Dynarex Corporation, Talent Healthcare, 3M, and Datt Mediproducts Pvt. Limited

I.V. (Intravenous) route is used by physicians, nurses etc. as the fastest route to deliver medications, fluids, blood transfusions, and others in patients. It is used in patients for fluid replacement, to maintain electrolyte balance, in patients with physical debility, and is also used to deliver medications, fluids etc. to unconscious patients as well. I.V. dressing acts as a quick fixation dressing to secure the I.V. cannula, intramuscular catheters, and other percutaneous devices to the skin. I.V. dressing is a transparent or translucent dressing made up of adhesive material and polyurethane collated films, it prevents bacterial infection at the injection site and also prevents moisture buildup to protect against dust and germs.

Market Dynamics

Increasing number of contracts and agreements by market players is expected to propel growth of the I.V. dressing market over the forecast period

In August 2016, Covalon Technologies Ltd., an advanced medical technologies company, secured a contract to supply its IV Clear antimicrobial silicone vascular access dressing at a minimum guaranteed value of US$ 3.5 million over twelve months, to the Ministry of Health facilities in Saudi Arabia

Key features of the study:

  • This report provides in-depth analysis of the global I.V. dressing market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global I.V. dressing market based on the following parameters – Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
  • Key companies covered as a part of this study include Becton, Dickinson and Company, Lohmann & Rauscher, Komal Health Care Pvt. Ltd., Paul Hartmann AG, DeRoyal Industries Inc., Tytex, Shandong Dermcosy Medical Co., Ltd., Smith & Nephew plc, Dynarex Corporation, Talent Healthcare, 3M, and Datt Mediproducts Pvt. Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global I.V. dressing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global I.V. dressing market.

Detailed Segmentation:

  • Global I.V. Dressing Market , By Product Type:
    • Transparent
    • Translucent
  • Global I.V. Dressing Market , By End User:
    • Hospital
    • Clinics
    • Others
  • Global I.V. Dressing Market , By Region:
    • North America
      • By Product Type
        • Transparent
        • Translucent
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product Type
        • Transparent
        • Translucent
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type
        • Transparent
        • Translucent
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Transparent
        • Translucent
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type
        • Transparent
        • Translucent
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Transparent
        • Translucent
      • By End User
        • Hospital
        • Clinics
        • Others
      • By Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Becton, Dickinson and Company*
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • Lohmann & Rauscher
    • Komal Health Care Pvt. Ltd.
    • Paul Hartmann AG
    • DeRoyal Industries Inc.
    • Tytex
    • Shandong Dermcosy Medical Co., Ltd.
    • Smith & Nephew plc
    • Dynarex Corporation
    • Talent Healthcare
    • 3M
    • Datt Mediproducts Pvt. Limited

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • I.V. Dressing Overview
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Porter’s Analysis
    • Product Portfolio Analysis
    • Company Market Share Analysis
  4. Global I.V. Dressing Market – Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • COVID-19 Considerations in the Catheterization Laboratory
    • Overall Impact on the Healthcare Industry
  5. Global I.V. Dressing Market, By Product Type, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Transparent
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Translucent
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
  6. Global I.V. Dressing Market, By End User, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, 2018 – 2028
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Mn)
  7. Global I.V. Dressing Market, By Region, 2021 – 2028, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2021 and 2028 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2028
    • North America
      • Market Size and Forecast, By Product Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By End User, 2021 – 2028, (US$ Mn)
      • Market Size and Forecast, By Country, 2021 – 2028, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Market Share Analysis
      • Becton, Dickinson and Company*
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Lohmann & Rauscher
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Komal Health Care Pvt. Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Paul Hartmann AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • DeRoyal Industries Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Tytex
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Shandong Dermcosy Medical Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Smith & Nephew plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Dynarex Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Talent Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • 3M
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Datt Mediproducts Pvt. Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 27 market data tables and 25 figures on "I.V. Dressing Market” - Global forecast to 2028

FAQgrowicon

Frequently Asked Questions

The global I.V. dressing market size is estimated to be valued at US$ 724.2 million in 2021 and is expected to exhibit a CAGR of 5.7% between 2021 and 2028.
Rising incidence of blood infections, number of surgeries, and increasing product approvals & launches are expected to drive the market growth over the forecast period.
Transparent segment is expected to hold the major market share, owing to increasing product approvals and launches during the forecast period.
North America holds the largest market share in the market.
Major factors hampering growth of the market include complications associated with I.V. dressing
Major players operating in the market include Becton, Dickinson and Company, Lohmann & Rauscher, Komal Health Care Pvt. Ltd., Paul Hartmann AG, DeRoyal Industries Inc., Tytex, Shandong Dermcosy Medical Co., Ltd., Smith & Nephew plc, Dynarex Corporation, Talent Healthcare, 3M and Datt Mediproducts Pvt. Limited
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner